Strauss David Eric 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Dec 16, 2020
Insider Transaction Report
Form 4
Strauss David Eric
Director, Corporate Controller
Transactions
- Award
Stock Option (right to buy)
2020-12-15+35,000→ 35,000 totalExercise: $2.97Exp: 2030-12-14→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.